HEIDELBERG, Germany--(BUSINESS WIRE)--BioPheresis GmbH has received a 2-year grant from the federal government for about 0.5 million Euros, to accelerate and expand the current and further work on a new cancer treatment with the company’s OncoSorb® column.
